Grating visual acuity results in the early treatment for retinopathy of prematurity study

Insights

Early treatment for retinopathy of prematurity (ROP) benefits type 1 cases, improving visual acuity. However, early treatment for type 2 ROP does not show a significant visual acuity advantage.

Area of Science:

  • Ophthalmology
  • Neonatal Medicine
  • Pediatric Vision

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of childhood blindness.
  • High-risk prethreshold ROP requires careful management to optimize visual outcomes.
  • Early intervention strategies are being evaluated to prevent vision loss in premature infants.

Purpose of the Study:

  • To compare grating visual acuity at age 6 in infants treated early (ET) versus those managed conventionally (CM) for high-risk prethreshold ROP.
  • To determine if early treatment for different types of prethreshold ROP impacts long-term visual acuity.

Main Methods:

  • Randomized clinical trial involving infants with bilateral high-risk prethreshold ROP.
  • One eye received early treatment (ET), the other conventional management (CM), with crossover if ROP progressed.
  • Grating visual acuity was assessed at 6 years of age using Teller acuity cards by masked testers.

Main Results:

  • No overall statistically significant difference in grating acuity between ET and CM for all high-risk prethreshold ROP.
  • Early treatment (ET) significantly improved grating acuity outcomes in type 1 ROP eyes compared to CM.
  • No significant visual acuity benefit was observed with ET in type 2 ROP eyes compared to CM.

Conclusions:

  • Early treatment is beneficial for type 1 retinopathy of prematurity, improving grating visual acuity outcomes.
  • Conventional management with cautious monitoring for progression is recommended for type 2 ROP, as early treatment did not improve acuity.
  • These findings support tailored treatment strategies for ROP based on disease type to preserve vision.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...